Asterias Biotherapeutics, Inc.

SEC insider activity covers quarterly filings through June 30, 2026. Later filings are not included. Reported roles do not establish current employment or current holdings. SEC filing documents, sections and filing-text search cover filings dated January 1, 2000 onward. Earlier filings are deferred until after launch.

organization

SEC Insider

$63.4M

182 transactions

Summary

Asterias Biotherapeutics, Inc. is an organization.

Recent Insider Transactions

As filed, including amendments; not net cash flow or current holdings. Joint reports count once. Totals cover known values only.

Buys: $6.3MSales: $324K25 insiders

Date	Insider	Type	Value
2019-03-01	Mulroy Michael H.(President and CEO)	F	$73K
2019-03-01	Wirth Edward(Chief Medical Officer)	F	$46K
2019-03-01	Chavez Ryan Daniel(CFO and General Counsel)	F	$42K
2019-01-02	Wirth Edward(Chief Medical Officer)	F	$14K
2019-01-02	Chavez Ryan Daniel(CFO and General Counsel)	F	$14K
2018-05-25	Mulroy Michael H.(President and CEO)	Buy	$5K
2018-06-25	Mulroy Michael H.(President and CEO)	Buy	$5K
2018-08-27	Mulroy Michael H.(President and CEO)	Buy	$5K
2018-07-25	Mulroy Michael H.(President and CEO)	Buy	$5K
2019-03-08	Joint reporting: BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; BRADSHER NEAL C	J	—
2019-03-08	Joint reporting: BROADWOOD PARTNERS, L.P.; BROADWOOD CAPITAL INC; BRADSHER NEAL C	J	$0
2019-03-01	Chavez Ryan Daniel(CFO and General Counsel)	A	$0
2019-03-01	Mulroy Michael H.(President and CEO)	A	$0
2019-03-01	Wirth Edward(Chief Medical Officer)	A	$0
2018-06-21	Arno Andrew	A	$0
2018-06-21	BAILEY DON M	A	$0
2018-06-21	Cartt Stephen LaHue	A	$0
2018-06-21	LeBuhn Richard T.	A	$0
2018-06-21	RICCIARDI NATALE S	A	$0
2018-06-21	Scher Howard Isador	A	$0

SEC filings: SEC EDGAR

Activity data: SEC EDGAR

Asterias Biotherapeutics, Inc. — Contributions, Lobbying & Contracts | Poliscope